BIRC5 and cancer: ABT-737 induced cell death by targeting anti-apoptotic Bcl-2 family proteins, whereas GCM potentiated the cancer cells to ABT-737 through suppressing TOPK/survivin axis and inhibiting de novo lipogenesis.